Trying to force CTIX into a premature deal is exactly what all the bashers on the other site are trying to do (as if their feeble posts would do that). The constant harping on uplisting as the cure to short attacks (see how well that worked for AVXL? [/sarcasm] ) and the agitation that Leo should take some deal, any deal or the company will go bankrupt (totally false, company has enough money to see these trials through to the point where it would make sense to have a partner) -- that shows what "they" want.

Personally I think it's nuts to think Leo is going to give away the store because a bunch of anonymous non-shareholders on the internet are saying he's a bad CEO so he should take their advice.

I trust the guy who saved the company with his own money, and who has gotten it into 4 clinical trials, to make the best decisions about when to start making deals with other companies. And I agree with lousy engineer that it isn't going to be the immediate future, at least as far as Kevetrin is concerned. Bril-OM could be the first, since those trials should have data pretty soon.